Induces apoptosis via the FasL signaling pathway, which involves a caspase-dependent FasL-mediated death receptor pathway; reduces cell viability, showing potential as a chemotherapeutic agent for oral cancer [256]. The gene discussed is FASLG; the disease is lip and oral cavity carcinoma.